Evidence map›Paper›PMID 42554315›Full record

ReviewChemistry, an Asian journal2026

Synthesis and Studies of BODIPY-Ferrocene Conjugates: An Overview.

Mushtaque A S Shaikh, Priti Khedkar, Shilpi Misra, Tamanna K Khan

Abstract readReview
In one paragraph

Review in Chemistry, an Asian journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mushtaque A S ShaikhDepartment of Pharmaceutical Chemistry, Vivekanand Education Society's College of Pharmacy, Mumbai, Maharashtra, India.ORCID https://orcid.org/0000-0003-3349-5057
Priti KhedkarDepartment of Chemistry, Guru Nanak Khalsa College of Arts, Science and Commerce (Autonomous), Mumbai, Maharashtra, India.
Shilpi MisraCentre For Scientific and Applied Research, IPS Academy, Indore, Madhya Pradesh, India.
Tamanna K KhanDepartment of Chemistry, Guru Nanak Khalsa College of Arts, Science and Commerce (Autonomous), Mumbai, Maharashtra, India.ORCID https://orcid.org/0009-0002-1898-2121

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Boron(III) difluoro dipyrromethene (BODIPY) dyes are known for their strong absorption, high fluorescence quantum yields, narrow emission bands, and high photostability. These properties make them suitable for sensing, imaging, and therapeutic applications. The incorporation of the redox-active ferrocene unit into the BODIPY framework yields donor-acceptor hybrid systems with fascinating electronic and photophysical properties. In these systems, photoinduced electron transfer often triggers fluorescence quenching and facilitates reversible electrochemical control of excited states. Structural modification of the BODIPY core, particularly through the incorporation of π-conjugated linkers (e.g., C═C and C≡C bonds) at the meso- and pyrrolic positions, extends the conjugation. These modifications enhance electronic communication between donor ferrocene and acceptor BODIPY and allow the incorporation of auxiliary units like porphyrin, pyrene, fullerene, and biotin. This review highlights recent advances in the synthesis of BODIPY-ferrocene conjugates using Sonogashira coupling, Knoevenagel condensation, and click chemistry. Their spectroscopic, electrochemical, and computational investigations are also described, including their tunable photophysical, redox properties, and prospective applications in sensors, molecular switches, and optoelectronic materials.

Indexed as

BODIPY‐ferrocene conjugatescharge transferdonor–acceptor systemelectronic structuresfluorescence quenchingredox processes

Identifiers

PMID42554315
PMCPMC13439728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.